Yufeng Wang

5.8k total citations · 1 hit paper
223 papers, 4.3k citations indexed

About

Yufeng Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yufeng Wang has authored 223 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Molecular Biology, 45 papers in Oncology and 37 papers in Cancer Research. Recurrent topics in Yufeng Wang's work include Tuberculosis Research and Epidemiology (22 papers), Mycobacterium research and diagnosis (20 papers) and RNA modifications and cancer (18 papers). Yufeng Wang is often cited by papers focused on Tuberculosis Research and Epidemiology (22 papers), Mycobacterium research and diagnosis (20 papers) and RNA modifications and cancer (18 papers). Yufeng Wang collaborates with scholars based in China, United States and Japan. Yufeng Wang's co-authors include Jianhua Yu, Jianying Zhang, Michael A. Caligiuri, Yasuhiro Kuramitsu, Yu Pang, Yanlin Zhao, Kazuyuki Nakamura, Don M. Benson, Zhijian Zhang and Takao Kitagawa and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yufeng Wang

213 papers receiving 4.2k citations

Hit Papers

Cancer-associated fibroblasts suppress ferroptosis and in... 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yufeng Wang China 35 1.9k 889 814 720 598 223 4.3k
Monica Neagu Romania 38 1.4k 0.8× 900 1.0× 626 0.8× 808 1.1× 553 0.9× 186 4.6k
Lu Gao China 41 2.1k 1.1× 900 1.0× 787 1.0× 1.2k 1.7× 1.5k 2.6× 254 5.9k
Min Luo China 36 2.3k 1.2× 706 0.8× 663 0.8× 665 0.9× 394 0.7× 206 4.9k
Xiaoming Sun China 33 3.1k 1.6× 822 0.9× 769 0.9× 1.1k 1.5× 445 0.7× 83 5.3k
Hideaki Ito Japan 34 2.2k 1.1× 686 0.8× 614 0.8× 429 0.6× 1.3k 2.1× 169 5.0k
Xia Liu China 32 1.9k 1.0× 645 0.7× 560 0.7× 820 1.1× 648 1.1× 157 4.7k
Xia Zhao China 40 3.5k 1.9× 1.5k 1.7× 1.1k 1.3× 1.2k 1.7× 310 0.5× 104 7.4k
Song Li United States 43 2.7k 1.4× 873 1.0× 577 0.7× 1.1k 1.5× 751 1.3× 171 5.8k
Xizhong Shen China 47 3.9k 2.0× 799 0.9× 1.4k 1.7× 499 0.7× 1.0k 1.8× 181 6.7k
Diana C. Haines United States 43 2.7k 1.4× 949 1.1× 761 0.9× 1.1k 1.5× 344 0.6× 63 5.3k

Countries citing papers authored by Yufeng Wang

Since Specialization
Citations

This map shows the geographic impact of Yufeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Wang more than expected).

Fields of papers citing papers by Yufeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Wang. The network helps show where Yufeng Wang may publish in the future.

Co-authorship network of co-authors of Yufeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Wang. A scholar is included among the top collaborators of Yufeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Wang. Yufeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yufeng, Niluja Thiruthaneeswaran, Lois Holloway, et al.. (2025). Longitudinal quantitative MRI in prostate cancer after radiation therapy with and without androgen deprivation therapy. Magnetic Resonance Imaging. 122. 110431–110431.
2.
Wang, Yufeng, et al.. (2025). PDP1 related ferroptosis risk signature indicates distinct immune microenvironment and prognosis of breast cancer patients. Frontiers in Pharmacology. 16. 1551325–1551325. 1 indexed citations
3.
4.
Kleynhans, Léanie, Alana Keyser, Niels D. Prins, et al.. (2025). Human alveolar macrophage function is impaired in tuberculosis contacts with diabetes. EBioMedicine. 122. 106050–106050.
6.
Liu, Cong, Yufeng Wang, Peng Wang, et al.. (2024). Predictive value of multiple imaging predictive models for spread through air spaces of lung adenocarcinoma: A systematic review and network meta‑analysis. Oncology Letters. 27(3). 122–122. 4 indexed citations
7.
Ding, Yijun, Yufeng Wang, Wei Jiang, et al.. (2023). CUL4B orchestrates mesenchymal stem cell commitment by epigenetically repressing KLF4 and C/EBPδ. Bone Research. 11(1). 29–29. 11 indexed citations
8.
Song, Chuanhui, Xinyu Zhang, Wei Zheng, et al.. (2023). Regulating tumor cholesterol microenvironment to enhance photoimmunotherapy in oral squamous cell carcinoma. Chemical Engineering Journal. 462. 142160–142160. 16 indexed citations
9.
Li, Xinxin, Xianchun Yan, Yufeng Wang, et al.. (2023). The Notch signaling pathway: a potential target for cancer immunotherapy. Journal of Hematology & Oncology. 16(1). 45–45. 92 indexed citations
10.
Qi, Ran, Yixuan Bai, Kun Li, et al.. (2023). Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resistance Updates. 68. 100960–100960. 190 indexed citations breakdown →
11.
Guan, Linbo, Ping Fan, Yufeng Wang, et al.. (2023). Lymphangiogenic responses of lymphatic endothelial cells to steady direct-current electric fields. Cell Adhesion & Migration. 17(1). 1–14. 4 indexed citations
12.
Xu, Shuwen, Xiaofeng Li, Longfei Li, et al.. (2021). CTCF-silenced miR-137 contributes to EMT and radioresistance in esophageal squamous cell carcinoma. Cancer Cell International. 21(1). 155–155. 9 indexed citations
13.
Gao, Tingting, Meng Lin, Qiao Zhou, et al.. (2020). BMI1 promotes steroidogenesis through maintaining redox homeostasis in mouse MLTC-1 and primary Leydig cells. Cell Cycle. 19(15). 1884–1898. 24 indexed citations
14.
Dong, Wenjuan, Xiaojin Wu, Shoubao Ma, et al.. (2019). The Mechanism of Anti–PD-L1 Antibody Efficacy against PD-L1–Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector. Cancer Discovery. 9(10). 1422–1437. 221 indexed citations
15.
Wang, Yufeng, Yibo Zhang, Tiffany Hughes, et al.. (2018). Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by Ex Vivo –Expanded Autologous NK Cells. Clinical Cancer Research. 24(16). 4006–4017. 96 indexed citations
16.
Wang, Youwei, Jianhong Chu, Ping Yi, et al.. (2018). SMAD4 promotes TGF-β–independent NK cell homeostasis and maturation and antitumor immunity. Journal of Clinical Investigation. 128(11). 5123–5136. 59 indexed citations
17.
Wang, Yufeng, Yasuhiro Kuramitsu, Byron Baron, et al.. (2015). PERK/CHOP contributes to the CGK733-induced vesicular calcium sequestration which is accompanied by non-apoptotic cell death. Oncotarget. 6(28). 25252–25265. 13 indexed citations
18.
Kuramitsu, Yasuhiro, Yufeng Wang, Takao Kitagawa, et al.. (2015). High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.. PubMed. 35(7). 3861–5. 14 indexed citations
19.
Chen, Qiang, et al.. (2012). Relationshap between human papillomavirus DNA testing and human telomerase RNA gene amplification detection in esophageal cancer tissue. Zhonghua shiyan waike zazhi. 29(7). 1355–1356. 2 indexed citations
20.
Wang, Yufeng. (2010). Clinical Observation on Palipeddone Sustained Release Tablet in the Treatment of Schizophrenia in Outpatient. Zhongguo yaofang. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026